A GLP-1 drug shortage has persisted since late 2022
In this case, the patient has achieved their goal weight, but their practitioner is wondering how to properly taper the dosage and whether full discontinuation has been successful for others
Sources: EMBRAZE Phase 2 press release Scholar Rock, June 2025 EMBRAZE full publication Nature Medicine, 2026 BELIEVE trial: bimagrumab + semaglutide HCPLive, May 2026 Lilly pauses bimagrumab trial BioPharma Dive, Sept
Right to Erasure (Right to Be Forgotten): You have the right to request the erasure of your data
The power of LipoC Now lets look at the second way we can help your weight loss efforts LipoC (lipotropic) injections
The weight loss from both medications comes from reduced appetite and slower stomach emptying, which leads to eating less without feeling deprived